Company: NDRA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110887
Chunk: 165

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 2
Chunk 165
---
2
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-09-30

    0001681682
    
      ndra:StockPayableMember

    2025-09-30

    0001681682
    
      us-gaap:RetainedEarningsMember

    2025-09-30

    0001681682
    
      us-gaap:SeriesAPreferredStockMember
      us-gaap:PreferredStockMember

    2024-06-30

    0001681682
    
      us-gaap:SeriesBPreferredStockMember
      us-gaap:PreferredStockMember

    2024-06-30

    0001681682
    
      us-gaap:CommonStockMember

    2024-06-30

    0001681682
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-06-30

    0001681682
    
      ndra:StockPayableMember

    2024-06-30

    0001681682
    
      us-gaap:RetainedEarningsMember

    2024-06-30

    0001681682

    2024-06-30

    0001681682
    
      us-gaap:SeriesAPreferredStockMember
      us-gaap:PreferredStockMember

    2024-07-01
    2024-09-30

    0001681682
    
      us-gaap:SeriesBPreferredStockMember
      us-gaap:PreferredStockMember

    2024-07-01
    2024-09-30

    0001681682
    
      us-gaap:CommonStockMember

    2024-07-01
    2024-09-30

    0001681682
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-07-01
    2024-09-30

    0001681682
    
      ndra:StockPayableMember

    2024-07-01
    2024-09-30

    0001681682
    
      us-gaap:RetainedEarningsMember

    2024-07-01
    2024-09-